Price T Rowe Associates Inc. MD Cuts Stock Position in Novavax, Inc. (NASDAQ:NVAX)
Price T Rowe Associates Inc. MD cut its stake in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 11.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 80,064 shares of the biopharmaceutical company’s stock after selling 10,159 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Novavax were worth […]
